Why The Aclaris Therapeutics Stock Increased 8.67% (ACRS)
Rheumatoid Arthritis (ATI-450-RA-202): This Phase 2b dose-ranging trial to investigate the efficacy, safety, tolerability, pharmacokinetics (PK) ... Rheumatoid Arthritis (ATI-450-RA-202): This Phase 2b dose-ranging trial to investigate the efficacy, safety,…